Pentixapharm Holding AG (PTP) | WebDisclosure

Basculer en Français

8295	Companies
114850	Keywords
55292	Articles
62440	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 10/29/2024 at 11:51, 22 days 23 hours ago

PentixaFor de Pentixapharm entre dans la phase d'essais cliniques avancés aux États-Unis

Essai Clinique Pentixapharm PentixaPour Tumeurs Surrénales Les Examens PET
PRESS RELEASE

published on 10/29/2024 at 11:46, 23 days ago

Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome

Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF

published on 10/28/2024 at 12:31, 23 days 23 hours ago

Ken Herrmann, expert en médecine nucléaire, rejoint le conseil d'administration de Pentixapharm

Conseil De Surveillance Produits Radiopharmaceutiques Médecine Nucléaire Ken Herrmann Pipeline En Oncologie
BRIEF

published on 10/28/2024 at 12:31, 23 days 23 hours ago

Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board

Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
PRESS RELEASE

published on 10/28/2024 at 12:26, 23 days 23 hours ago

Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG
Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline

Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
BRIEF

published on 10/25/2024 at 16:05, 26 days 19 hours ago

Pentixapharm Holding AG Announces Leadership Changes

Leadership Changes Supervisory Board Pentixapharm Dr. Hakim Bouterfa Dr. Dirk Pleimes
BRIEF

published on 10/25/2024 at 16:05, 26 days 19 hours ago

Pentixapharm Holding AG annonce des changements au sein de sa direction

Conseil De Surveillance Changements De Direction Pentixapharm Docteur Hakim Bouterfa Dr Dirk Pleimes
PRESS RELEASE

published on 10/25/2024 at 16:00, 26 days 19 hours ago

Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group
Pentixapharm Holding AG announces upcoming changes in management and supervisory boards, including CEO transition and new board appointments

CEO Transition Supervisory Board Management Changes Pentixapharm Holding AG Nuclear Medicine Specialist
BRIEF

published on 10/19/2024 at 12:33, 1 month 1 day ago

Pentixapharm's CXCR4 Compound Showcased at EANM Conference

Radiopharmaceuticals Pentixapharm CXCR4 Targeting EANM Conference Theranostic Development
BRIEF

published on 10/19/2024 at 12:33, 1 month 1 day ago

Le composé CXCR4 de Pentixapharm présenté à la conférence EANM

Produits Radiopharmaceutiques Pentixapharm Ciblage CXCR4 Conférence EANM Développement Théranostique

Accesswire

Published on 11/21/2024 at 11:30, 20 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 47 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 50 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 50 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 15 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:30, 20 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 49 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 50 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 54 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 20 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 52 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 43 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 30 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE